⚠All products sold strictly for in vitro research and laboratory use only. Not for human or veterinary consumption.
Research Reading
BLOG
Reference articles on melanocortin peptide biology, and the differences between Melanotan 1 and Melanotan 2 as research compounds. Written for laboratory and academic research context.
Research PrimerUpdated 2026
What Are Research Peptides, Exactly?
Peptides are short chains of amino acids linked by peptide bonds — smaller than proteins, but built from the same molecular building blocks. In a laboratory research context, synthetic peptides are used as tools to probe how specific receptors, enzymes, and signalling pathways behave, because their structure can be precisely controlled and modified in ways that naturally occurring hormones often can't be.
"Research peptide" is a broad label covering many different compound classes: growth-factor analogues, hormone mimetics, and receptor agonists or antagonists among them. Melanotan 1 and Melanotan 2 fall into the melanocortin category — synthetic analogues of alpha-melanocyte-stimulating hormone (α-MSH), a peptide the body produces naturally to regulate pigmentation, inflammation, and aspects of energy balance.
Why Purity and Sourcing Matter
Because peptides are reactive, biologically active molecules, the reliability of any research finding depends heavily on the quality of the material used. Batch-to-batch variation, degradation from poor storage, or contamination can all confound results. This is why serious research suppliers verify every batch by HPLC (high-performance liquid chromatography) and mass spectrometry, and why researchers are advised to check certificates of analysis before use.
This article is provided for general educational reference only and does not constitute medical, dosing, or usage advice. MelanoMax products are supplied strictly for in vitro laboratory research and are not approved for human or veterinary use.
Peptides 101Research
Compound ComparisonUpdated 2026
Melanotan 1 vs. Melanotan 2: What's the Difference?
Both Melanotan 1 (afamelanotide) and Melanotan 2 are synthetic analogues of α-MSH, but they were developed at different times, have different molecular structures, and interact with melanocortin receptors differently — which is why researchers treat them as distinct compounds rather than interchangeable versions of the same peptide.
Melanotan 1
MT-1 is a linear peptide, structurally closer to the native α-MSH sequence, with high selectivity for the MC1R receptor. It was the first of the two to be synthesised, at the University of Arizona in 1980, and its receptor selectivity has made it the more extensively studied of the pair in a clinical context — it's the basis of afamelanotide (Scenesse), approved by the EMA in 2014 for a specific rare skin condition.
Melanotan 2
MT-2 is a cyclic analogue, synthesised over a decade later. Its cyclic (lactam-bridged) structure gives it broader receptor activity, engaging MC1R, MC3R, MC4R, and MC5R rather than MC1R alone. That broader receptor profile is why MT-2 has been used more widely as a general-purpose tool in melanocortin pathway research, including studies touching on energy homeostasis via MC4R.
Key Differences at a Glance
Structure: MT-1 is linear; MT-2 is cyclic.
Receptor selectivity: MT-1 is MC1R-selective; MT-2 engages multiple melanocortin receptors.
Molecular weight: MT-1 ≈ 1647.8 Da; MT-2 ≈ 1024.2 Da.
Regulatory status: MT-1's analogue afamelanotide has an approved clinical indication in the EU; MT-2 does not have an approved therapeutic use anywhere.
Stability: both incorporate D-amino acid substitutions that improve resistance to enzymatic degradation relative to native α-MSH, aiding reproducibility in multi-day in vitro assays.
This comparison is provided for educational reference only. It is not medical advice and does not describe or endorse human use. See our Science page for full technical specifications.
MT-1MT-2Comparison
MechanismUpdated 2026
How Melanocortin Receptor Agonists Work
Both MT-1 and MT-2 act through the same broad mechanism: binding to melanocortin receptors on the cell surface and triggering a cascade of intracellular signalling. Understanding this pathway is central to interpreting any in vitro result involving these compounds.
The Signalling Cascade
Receptor binding activates adenylyl cyclase via Gs proteins, raising intracellular cyclic AMP (cAMP). Elevated cAMP activates the CREB transcription factor, which upregulates MITF and tyrosinase — the enzyme that catalyses the rate-limiting step of melanin synthesis. In melanocyte cell cultures, this produces a measurable, dose-dependent increase in melanin production, which is one of the most common in vitro readouts used in melanocortin research.
Beyond Pigmentation
Because MC1R and MC3R activation also suppresses NF-κB signalling and downstream inflammatory mediators like TNF-α and IL-6, melanocortin agonists are additionally used as research tools in inflammation models — for example in macrophage and keratinocyte cell lines. MC4R engagement (relevant mainly to MT-2, given its broader receptor profile) has separately made these peptides useful in experimental models of appetite and energy-balance signalling.
For full technical specifications — sequences, molecular formulas, and a research timeline — see the Science page.
Educational reference only, describing in vitro laboratory findings. Not medical advice, and not a description of human use.